Intelligent Medicine Acquisition Corp. Stock: price and insider trades · United States

Intelligent Medicine Acquisition Corp.: what insiders have been doing

Insider filings for Intelligent Medicine Acquisition Corp. are scarce in the SEC (Form 4) feed, the latest one published on 28 February 2023. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Insider Decl.

Thresholds

n/a

Buy Volume

n/a

Sell Volume

n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2022

FY ended December 2022 · cache

Income statement

Net income10.2M

Last declaration on 28 February 2023

Declarations1 total

●

Saba Capital Management, L.P.

Related company / holdingExecutives24 Feb 2023

22M USD10SEC ↗

2,170,581 shares@ US$10.34100.0% of flowCommon StockSEC:0001510281-23-000025:0

1 of 1 declaration

About Intelligent Medicine Acquisition Corp.

Intelligent Medicine Acquisition Corp. is a special purpose acquisition company focused on the healthcare sector. It is listed on NASDAQ under the ticker IMAC.